Results 21 to 30 of about 257,551 (158)

Insulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphoma. [PDF]

open access: yesPLoS ONE, 2014
The interaction between the tumor cells in classical Hodgkin lymphoma (cHL) and the microenvironment includes aberrant activity of receptor tyrosine kinases.
Zheng Liang   +6 more
doaj   +1 more source

Association of Insulin-like Growth Factor 1 Receptor with EHD1 and SNAP29 [PDF]

open access: yesJournal of Biological Chemistry, 2001
Ligand-induced receptor-mediated endocytosis plays a central role in regulating signaling conveyed by tyrosine kinase receptors. This process depends on the recruitment of the adaptor protein 2 (AP-2) complex, clathrin, dynamin, and other accessory proteins to the ligand-bound receptor.
R, Rotem-Yehudar   +2 more
openaire   +2 more sources

IGF-Binding Proteins: Why Do They Exist and Why Are There So Many?

open access: yesFrontiers in Endocrinology, 2018
Insulin-like growth factors (IGFs) are key growth-promoting peptides that act as both endocrine hormones and autocrine/paracrine growth factors. In the bloodstream and in local tissues, most IGF molecules are bound by one of the members of the IGF ...
John B. Allard, Cunming Duan
doaj   +1 more source

Expression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLD.

open access: yesPLoS ONE, 2018
Background and aimsNonalcoholic fatty liver disease is one of the major complications of obesity, occurring already in pediatric age. Insulin like growth factor-I has been proposed as a potential therapeutic agent for its beneficial effect in ...
Anna Alisi   +6 more
doaj   +1 more source

Knockout of insulin-like growth factor-1 receptor impairs distal lung morphogenesis. [PDF]

open access: yesPLoS ONE, 2012
BACKGROUND: Insulin-like growth factors (IGF-I and -II) are pleiotropic regulators of somatic growth and development in vertebrate species. Endocrine and paracrine effects of both hormones are mediated by a common IGF type 1 receptor (IGF-1R).
Ralph Epaud   +13 more
doaj   +1 more source

Role of insulin-like growth factor 1 receptor signalling in cancer [PDF]

open access: yesBritish Journal of Cancer, 2005
The insulin-like growth factor (IGF-1) signalling is highly implicated in cancer. In this signalling the IGF-1 receptor (IGF-1R) is unquestionable, the predominating single factor. IGF-1R is crucial for tumour transformation and survival of malignant cell, but is only partially involved in normal cell growth.
Larsson, O, Girnita, A, Girnita, L
openaire   +3 more sources

MiR-205 serves as a prognostic factor and suppresses proliferation and invasion by targeting insulin-like growth factor receptor 1 in human cervical cancer

open access: yesTumor Biology, 2017
MicroRNAs are a kind of small and non-coding RNAs, which have been demonstrated to play an important role in the progression of human cervical cancer.
Hui Pang, Xiuying Yue
doaj   +1 more source

Insulin-Like Growth Factor-1 Receptor Expression in Thymic Malignancies [PDF]

open access: yesJournal of Thoracic Oncology, 2010
Thymic epithelial tumors are rare mediastinal malignancies that can be invasive and difficult to treat. Insulin-like growth factor-1 receptor (IGF-1R) is a transmembrane receptor implicated in the regulation of cell metabolism, growth, and survival. As higher levels of IGF-1R protein expression may be associated with relative sensitivity to anti-IGF-1R
Girard, Nicolas   +6 more
openaire   +2 more sources

Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report

open access: yesJournal of Medical Case Reports, 2021
Background Adjuvant endocrine therapy is recommended for the treatment of hormone-receptor-positive breast cancer. Aromatase inhibitors are associated with significant musculoskeletal adverse effects, likely through growth hormone/insulin-like growth ...
Sasan Mirfakhraee   +3 more
doaj   +1 more source

Identification of BRCA1 As a Potential Biomarker for Insulin-Like Growth Factor-1 Receptor Targeted Therapy in Breast Cancer

open access: yesFrontiers in Endocrinology, 2017
The insulin-like growth factor-1 receptor (IGF1R) emerged in recent years as a promising therapeutic target in oncology. Identification of potential biomarkers capable of predicting response to IGF1R-targeted therapy is of cardinal importance.
Tali Cohen-Sinai   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy